Pillstats
Rx only · Injection, Powder, Lyophilized, For Solution · Intravenous

Daptomycin

Brands: Dapzura Rt · Daptomycin

21 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US40 NDCs
21 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCJ01XX09
RxCUI (US)22299
US makers21 labelers
Packages52
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 40 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$5.39$10.79$16.18$21.58Jul 2025Apr 2026Jul 2026
$18.256
Latest avg · Jul 22, 2026
+36%
Since Jul 23, 2025
21
Active US suppliers
23%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

18K35K53K70K2025 Q12025 Q22025 Q32025 Q42026 Q1
36K
Rx · 2026 Q1
359K
Units dispensed
-28%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it21 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Sagent Pharmaceuticalsunknown6SUPPLYING
Hikma Pharmaceuticals USA Inc.unknown6SUPPLYING
Meitheal Pharmaceuticals Inc.unknown5SUPPLYING
Xellia Pharmaceuticals USA LLCunknown5SUPPLYING
BE Pharmaceuticals Inc.unknown3SUPPLYING
Civica, Inc.unknown3SUPPLYING
Accord Healthcare Inc.unknown3SUPPLYING
Dr.Reddy's laboratories Limitedunknown3SUPPLYING
Camber Pharmaceuticals, Inc.unknown3SUPPLYING
Hospira, Inc.unknown2SUPPLYING
Mylan Institutional LLCunknown2SUPPLYING
Fresenius Kabi USA, LLCunknown2SUPPLYING
NorthStar RxLLCunknown2SUPPLYING
Qilu Pharmaceutical Co. Ltd.unknown1SUPPLYING
Biocon Pharma Incunknown1SUPPLYING

+ 6 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jun 30, 2026
    RESOLVEDShortage resolved: Daptomycin Injection (Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.))

    Daptomycin Injection — reported in shortage by Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.). Therapeutic category: Anti-Infective.

  • Jun 30, 2026
    SHORTAGEDrug shortage: Daptomycin Injection (Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.))

    Daptomycin Injection — reported in shortage by Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.). Therapeutic category: Anti-Infective.

  • Feb 7, 2023
    RECALLRecall (Class II): Daptomycin for Injection 350 mg/vial, Rx only, Packaged as: a) Single-dose vial NDC 16729-434-05 UPC 3 16729 43405 8; b…

    CGMP Deviations: recalling drug products following an FDA inspection. — Recalling firm: Accord Healthcare, Inc. — United States including Puerto Rico and Canada

  • Feb 7, 2023
    RECALLRecall (Class II): Daptomycin for Injection 500 mg per vial, Single-dose vial, Rx only, Manufactured by: Intas Pharmaceuticals Limited, Ph…

    CGMP Deviations: recalling drug products following an FDA inspection. — Recalling firm: Accord Healthcare, Inc. — United States including Puerto Rico and Canada

  • Jul 7, 2020
    RECALLRecall (Class I): Daptomycin for Injection, 500 mg/vial, Single-Dose Vial, Rx only, Sterile, Manufactured for: Mylan Institutional, LLC, …

    Presence of Particulate Matter — Recalling firm: Mylan Institutional LLC — USA Nationwide